Drug Approvals Bounce Back as R&D Labs Churn Out New Winners

Today we're bringing you a recent article out of Reuters Health that address the number of new drugs approved in the United States and Europe bouncing back.

Ben Hirschler writes, "John LaMattina, a former research head for Pfizer and a board member at PureTech Health, is unsurprised by the rebound and believes concerns raised at the end of 2016 about deteriorating drug pipelines were "far too dire".

Hirschler also notes that drugmakers are getting smarter about the way they're developing medicines by shifting from mass market product to high dollar therapies. 

To learn more on this topic, please read the full article HERE!

Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.